Subject: illegal drug use | risk taking | risk reduction | drug quality | Addiction Debate | drug harms | darknet | drug dealing | Cryptomarkets | drug prices | harm reduction
Background: Cryptomarkets – online, anonymous marketplaces for illicit goods and services that mostly specialise in drugs – account for a small but rapidly growing share of the illicit drug market in many countries. Policy responses so far are generally based on the ass... View more
1. Barratt M. J., Aldridge J. Everything you always wanted to know about drug cryptomarkets* (*but were afraid to ask). Int J Drug Policy 2016; 35: 1-6.
2. Aldridge J, Décary-Hétu D. Not an 'Ebay for drugs': the Cryptomarket 'Silk Road' as a paradigm shifting criminal innovation. SSRN. Available at: http://ssrncom/abstract= 2436643 (accessed 31 March 2017) (Archived at http:// www.webcitation.org/6pNFYrG2y).
3. Martin J. Drugs on the Dark Net: How Cryptomarkets are Transforming the Global Trade in Illicit Drugs. Basingstoke: Palgrave Macmillan; 2014.
4. Barratt M. J. Silk Road: eBay for drugs. Addiction 2012; 107: 683.
5. Van Buskirk J., Roxburgh A., Farrell M., Burns L. The closure of the Silk Road: what has this meant for on-line drug trading? Addiction 2014; 109: 517-8.
6. Mounteney J., Oteo A., Griffiths P. The internet and drug markets: shining a light on these complex and dynamic systems. In: European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), editor. The Internet and Drug Markets (EMCDDA Insights 21). Luxembourg: Publications Office of the European Union; 2016, pp. 13-7.
7. Pompidou Group. Drug Related Cybercrime and Associated Use of the Internet: Overview, analysis and possible actions by the Pompidou Group. Strasbourg: Council of Europe; 2013.
8. Pompidou Group. Drug Related Cybercrime. Monitoring Report July-August 2015. Council of Europe: Strasbourg; 2015.
9. Aldridge J., Décary-Hétu D. Hidden wholesale: how drug cryptomarkets may transform traditional 'off-line' drug markets. Int J Drug Policy 2016; 35: 7-15.
10. Winstock A. R., Barratt M., Ferris J., Maier L. What we learned from GDS2016: an overview of our key findings. 2016. Available at: https://www.globaldrugsurvey.com/wpcontent/uploads/2016/06/TASTER-KEY-FINDINGS-FROMGDS2016.pdf (accessed 31 March 2017) (Archived at http:// www.webcitation.org/6pNFgGwNr).